Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 13 03 2020
revised: 20 05 2020
pubmed: 15 8 2020
medline: 23 4 2021
entrez: 15 8 2020
Statut: ppublish

Résumé

To establish optimal cut-off values for the scores of the revised Fibromyalgia Impact Questionnaire (FIQR), the modified Fibromialgia Assessment Scale (FAS 2019mod), and the Polysymptomatic Distress Scale (PDS) in order to distinguish five levels of FM disease severity. Consecutive FM patients were evaluated with the three clinimetric indices, and each patient was required to answer the anchor question: 'In general, would you say your health is 1 = very good, 2 = good, 3 = fair, 4 = poor, or 5 = very poor?'-which represented the external criterion. Cut-off points were established through the interquartile reconciliation approach. The study sample consisted of 2181 women (93.2%) and 158 men (6.8%), with a mean age of 51.9 (11.5) years, and mean disease duration was 7.3 (6.9) years. The overall median FIQR, FAS 2019 mod and PDS scores (25th-75th percentiles) were respectively 61.16 (41.16-77.00), 27.00 (19.00-32.00) and 19.0 (13.00-24.00). Reconciliation of the mean 75th and 25th percentiles of adjacent categories defined the severity states for FIQR: 0-23 for remission, 24-40 for mild disease, 41-63 for moderate disease, 64-82 for severe disease and >83 for very severe disease; FAS 2019 mod: 0-12 for remission, 13-20 for mild disease, 21-28 for moderate disease, 29-33 for severe disease and >33 for very severe disease; PDS: 0-5 for remission, 6-15 for mild disease, 16-20 for moderate disease, 21-25 for severe disease and >25 for very severe disease. Disease severity cut-offs can represent an important improvement in interpreting FM.

Identifiants

pubmed: 32793982
pii: 5892430
doi: 10.1093/rheumatology/keaa355
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

728-736

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Fausto Salaffi (F)

Rheumatology Clinic, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Jesi (Ancona), Italy.

Marco Di Carlo (M)

Rheumatology Clinic, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Jesi (Ancona), Italy.

Laura Bazzichi (L)

Rheumatology Unit, AOU Pisana, Pisa, Italy.

Fabiola Atzeni (F)

Rheumatology Unit, Department of Internal Medicine, University of Messina, Messina, Italy.

Marcello Govoni (M)

Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria di Ferrara, Ferrara, Italy.

Giovanni Biasi (G)

Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.

Manuela Di Franco (M)

Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences Rheumatology Unit- Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

Flavio Mozzani (F)

Internal Medicine and Rheumatology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.

Elisa Gremese (E)

UOC Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Lorenzo Dagna (L)

Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy.

Alberto Batticciotto (A)

Rheumatology Unit, Internal Medicine Department, ASST Settelaghi, Ospedale Di Circolo - Fondazione Macchi, Varese, Italy.

Fabio Fischetti (F)

Department of Medical Sciences, University of Trieste, UCO Medicina Clinica (SSD Reumatologia), Trieste, Italy.

Roberto Giacomelli (R)

Clinical Unit of Rheumatology, School of Medicine, University of L'Aquila, L'Aquila, Italy.

Serena Guiducci (S)

Department of Experimental and Clinical Medicine, Divisions of Internal Medicine and Rheumatology AOUC, University of Florence, Florence, Italy.

Giuliana Guggino (G)

Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.

Mario Bentivegna (M)

Integrated Reference Center of Rheumatology, ASP 7, Scicli Hospital, Ragusa, Italy.

Roberto Gerli (R)

Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy.

Carlo Salvarani (C)

University of Modena and Reggio Emilia, Azienda USL-IRCCS di Reggio Emilia, Modena, Italy.

Gianluigi Bajocchi (G)

Rheumatology Unit, S. Maria Hospital-USL, IRCCS Institute, Reggio Emilia, Italy.

Marco Ghini (M)

Rheumatology Unit, Azienda USL di Modena, Modena, Italy.

Florenzo Iannone (F)

Rheumatology Unit, Department of Emergency and Organ Transpantations, University of Bari, Bari, Italy.

Valeria Giorgi (V)

Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan State University School of Medicine, Milan, Italy.

Sonia Farah (S)

Rheumatology Clinic, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Jesi (Ancona), Italy.

Mariateresa Cirillo (M)

Rheumatology Unit, Department of Internal Medicine, University of Messina, Messina, Italy.

Sara Bonazza (S)

Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria di Ferrara, Ferrara, Italy.

Stefano Barbagli (S)

Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.

Chiara Gioia (C)

Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences Rheumatology Unit- Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

Daniele Santilli (D)

Internal Medicine and Rheumatology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.

Annunziata Capacci (A)

UOC Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Giulio Cavalli (G)

Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy.

Francesco Carubbi (F)

Clinical Unit of Rheumatology, School of Medicine, University of L'Aquila, L'Aquila, Italy.

Francesca Nacci (F)

Department of Experimental and Clinical Medicine, Divisions of Internal Medicine and Rheumatology AOUC, University of Florence, Florence, Italy.

Ilenia Riccucci (I)

Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy.

Luigi Sinigaglia (L)

Division of Rheumatology, ASST Gaetano Pini-CTO, Milan, Italy.

Maurizio Masullo (M)

Ministry of Health, General Directorate of Health Care, Rome, Italy.

Bianca Maria Polizzi (BM)

Ministry of Health, General Directorate of Health Care, Rome, Italy.

Maurizio Cutolo (M)

Research Laboratory and Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS San Martino, University of Genova, Genova, Italy.

Piercarlo Sarzi-Puttini (P)

Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan State University School of Medicine, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH